Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BASE Trial
ISRCTN18260410Phase 4Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Feb 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate in metabolic acidosis (2 arms), sponsored by University of Oxford. Primary endpoint: Survival without major morbidity. Started Feb 2024; status: active, not recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
metabolic acidosis
Beyond the preview
Go deeper on ISRCTN18260410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18260410.